157 related articles for article (PubMed ID: 26500541)
1. Hypercalcemia-Induced Hypokalemic Metabolic Alkalosis in a Multiple Myeloma Patient: The Risk of Furosemide Use.
Reiser IW; Ali S; Gotlieb V; Spitalewitz S
Case Rep Oncol; 2015; 8(3):389-93. PubMed ID: 26500541
[TBL] [Abstract][Full Text] [Related]
2. Impaired response to furosemide in hyperprostaglandin E syndrome: evidence for a tubular defect in the loop of Henle.
Köckerling A; Reinalter SC; Seyberth HW
J Pediatr; 1996 Oct; 129(4):519-28. PubMed ID: 8859258
[TBL] [Abstract][Full Text] [Related]
3. A Case of Milk-Alkali Syndrome Caused by Diuretic-Induced Alkalosis and Polypharmacy.
Mizutani N; Goda K; Kenzaka T
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512156
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia-induced hypokalemic metabolic alkalosis with hypophosphatemia in a multiple myeloma patient: lessons for the clinical nephrologist.
Ghumman GM; Haider M; Raffay EA; Cheema HA; Yousaf A
J Nephrol; 2023 Mar; 36(2):315-317. PubMed ID: 36269493
[No Abstract] [Full Text] [Related]
5. Multiple myeloma with hypercalcemia and chloride resistant metabolic alkalosis.
Alshayeb H; Patel V; Naseer A; Mangold TA; Wall BM
Tenn Med; 2011 Oct; 104(9):47-9. PubMed ID: 22073517
[TBL] [Abstract][Full Text] [Related]
6. [HYPOKALEMIC METABOLIC ALKALOSIS – A REPORT OF SIX CASES].
Galešić K; Horvatić I; Ilić M; Ćuk M; Crnogorac M; Ljubanović DG
Lijec Vjesn; 2016; 138(9-10):260-5. PubMed ID: 30148552
[TBL] [Abstract][Full Text] [Related]
7. A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus, and nephrocalcinosis in four patients.
Wongsaengsak S; Vidmar AP; Addala A; Kamil ES; Sequeira P; Fass B; Pitukcheewanont P
Bone; 2017 Apr; 97():121-125. PubMed ID: 28095294
[TBL] [Abstract][Full Text] [Related]
8. Effect of furosemide-induced hypokalemic metabolic alkalosis on renal transport enzymes.
Eiam-Ong S; Kurtzman NA; Sabatini S
Kidney Int; 1993 May; 43(5):1015-20. PubMed ID: 8389946
[TBL] [Abstract][Full Text] [Related]
9. Studies on the site of renal tubular defect in Bartter's syndrome.
Kikuchi M; Sato M; Chiba A; Chiba Y; Nagao K; Suzuki T; Fujigaki Y; Hoshino H
Acta Paediatr Jpn; 1997 Jun; 39(3):358-61. PubMed ID: 9241901
[TBL] [Abstract][Full Text] [Related]
10. Diminished diuretic and natriuretic response to furosemide in potassium-depleted rats.
Hropot M; Klaus E; Unwin R; Giebisch G
Ren Physiol Biochem; 1994; 17(1):10-20. PubMed ID: 7509499
[TBL] [Abstract][Full Text] [Related]
11. Azosemide, a "loop" diuretic, and furosemide.
Brater DC; Anderson SA; Strowig S
Clin Pharmacol Ther; 1979 Apr; 25(4):435-9. PubMed ID: 428188
[TBL] [Abstract][Full Text] [Related]
12. Factitious Bartter's syndrome induced by surreptitious intake of furosemide.
Sekine K; Kojima I; Fujita T; Uchino K; Isozaki S; Ogata E
Endocrinol Jpn; 1982 Oct; 29(5):653-7. PubMed ID: 7182184
[TBL] [Abstract][Full Text] [Related]
13. Diuretic complications.
Greenberg A
Am J Med Sci; 2000 Jan; 319(1):10-24. PubMed ID: 10653441
[TBL] [Abstract][Full Text] [Related]
14. Diuretic use in critical care.
Narins RG; Chusid P
Am J Cardiol; 1986 Jan; 57(2):26A-32A. PubMed ID: 3511655
[TBL] [Abstract][Full Text] [Related]
15. Hypokalemic metabolic alkalosis with hypomagnesuric hypermagnesemia and severe hypocalciuria: a new syndrome?
Mehrotra R; Nolph KD; Kathuria P; Dotson L
Am J Kidney Dis; 1997 Jan; 29(1):106-14. PubMed ID: 9002538
[TBL] [Abstract][Full Text] [Related]
16. Role of citrate excretion in acid-base balance in diuretic-induced alkalosis in the rat.
Kaufman AM; Brod-Miller C; Kahn T
Am J Physiol; 1985 Jun; 248(6 Pt 2):F796-803. PubMed ID: 2988348
[TBL] [Abstract][Full Text] [Related]
17. Site and mechanism of action of diuretics.
Kokko JP
Am J Med; 1984 Nov; 77(5A):11-7. PubMed ID: 6496555
[TBL] [Abstract][Full Text] [Related]
18. [A case of Gitelman's syndrome presenting with severe hypocalcaemia and hypokalemic periodic paralysis].
Ran XW; Wang C; Dai F; Jiang JJ; Tong NW; Li XJ; Liang JZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):583-7. PubMed ID: 16078592
[TBL] [Abstract][Full Text] [Related]
19. Dose-related effects of furosemide, bumetanide, and piretanide on the thick ascending limb function in the rat.
Gutsche HU; Müller-Ott K; Brunkhorst R; Niedermayer W
Can J Physiol Pharmacol; 1983 Feb; 61(2):159-65. PubMed ID: 6301665
[TBL] [Abstract][Full Text] [Related]
20. Possible discrimination of Gitelman's syndrome from Bartter's syndrome by renal clearance study: report of two cases.
Tsukamoto T; Kobayashi T; Kawamoto K; Fukase M; Chihara K
Am J Kidney Dis; 1995 Apr; 25(4):637-41. PubMed ID: 7702064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
